Cancer, Colorectal Clinical Trials

• A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-Line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Mestastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00478634 - Recruiting
  Colorectal Cancer; Colorectal Carcinoma; Colorectal Tumors; Neoplasms, Colorectal
  
• Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00352638 - Active, not recruiting
  Colorectal Cancer
  
• Computerized and Mailed Reminders in Increasing the Rate of Colorectal Cancer Screening in Adults With an Average Risk for Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00355004 - Active, not recruiting
  Colorectal Cancer
  
• Cetuximab and Celecoxib in Treating Patients With Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00466505 - Active, not recruiting
  Colorectal Cancer
  
• A Study of Avastin with Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00097578 - Active, not recruiting
  Colorectal Cancer
  
• Colorectal Cancer Control in Appalachian Churches
  ClinicalTrials.gov Identifier: NCT00137683 - Active, not recruiting
  Colorectal Cancer
  
• GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
  ClinicalTrials.gov Identifier: NCT00044343 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• Safety/Efficacy of Camptosar, Avastin, & 5-FU/LV 2-Schedules w/ Celebrex/Placebo as Colorectal Cancer Initial Treatment
  ClinicalTrials.gov Identifier: NCT00101686 - Active, not recruiting
  Colorectal Cancer; Metastases
  
• A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00437268 - Recruiting
  Colorectal Cancer; Colorectal Carcinoma; Colorectal Tumor
  
• Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment
  ClinicalTrials.gov Identifier: NCT00411450 - Recruiting
  Colon Cancer; Colorectal Cancer; Rectal Cancer; Cancer; Metastatic Cancer; Metastatic Colorectal Cancer; Oncology
  
• Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00450424 - Recruiting
  Colorectal Cancer; Hereditary Non-Polyposis Colon Cancer (hmsh2, hmlh1, hpms1, hpms2)
  
• Translation of Colorectal Cancer Screening Guidelines to Practice
  ClinicalTrials.gov Identifier: NCT00122187 - Active, not recruiting
  Colorectal Cancer; Colorectal Neoplasms; Colonic Neoplasms; Colonic Diseases
  
• Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
  ClinicalTrials.gov Identifier: NCT00005094 - Active, not recruiting
  prevention of colorectal cancer; Colon Cancer; Rectal Cancer
  
• Assessment of Frequency of Surveillance After Curative Resection in Patients with Stage II and III Colorectal Cancer.
  ClinicalTrials.gov Identifier: NCT00225641 - Recruiting
  Colorectal Cancer
  
• High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed
  ClinicalTrials.gov Identifier: NCT00002650 - Active, not recruiting
  Rectal Cancer; prevention of colorectal cancer; Colon Cancer
  
• NORCCAP: Norwegian Colorectal Cancer Prevention Trial
  ClinicalTrials.gov Identifier: NCT00119912 - Active, not recruiting
  Colorectal Cancer; Adenoma
  
• Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00468910 - Recruiting
  Colorectal Cancer; Precancerous/Nonmalignant Condition
  
• A Trial of ABX-EGF Monotherapy in Subjects with Metastatic Colorectal Cancer Following Treatment with Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy
  ClinicalTrials.gov Identifier: NCT00083616 - Active, not recruiting
  Colorectal Cancer; Metastases
  
• Preoperative Assessment of Colon Tumor
  ClinicalTrials.gov Identifier: NCT00114829 - Recruiting
  Colorectal Cancer; Colorectal Tumor
  
• DAVANAT Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00110721 - Active, not recruiting
  Colorectal Cancer
  
• Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver
  ClinicalTrials.gov Identifier: NCT00020501 - Active, not recruiting
  Colorectal Cancer; Metastatic Cancer
  
• A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women
  ClinicalTrials.gov Identifier: NCT00376909 - Active, not recruiting
  Breast Cancer; Cervical Cancer; Colorectal Cancer
  
• Evaluating ABX-EGF in Patients with Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00111761 - Active, not recruiting
  Colorectal Cancer
  
• Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00126256 - Recruiting
  Colorectal Cancer; Metastasis
  
• Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer
  ClinicalTrials.gov Identifier: NCT00310076 - Active, not recruiting
  Carcinoma of the Appendix; Colorectal Cancer
  
• Comparison of Laparoscopic Colectomy Verus Open Colectomy for Colorectal Cancer: … A Prospective Randomized Trial.
  ClinicalTrials.gov Identifier: NCT00155727 - Recruiting
  Colorectal Cancer
  
• A Phase 2 Study of Single Agent EKB-569 in Subjects with Advanced Colorectal Cancer.
  ClinicalTrials.gov Identifier: NCT00072748 - Active, not recruiting
  Colorectal Cancer
  
• A 2x2 (4-way) study of capecitabine in combo w/ oxaliplatin (XELOX) w/ or w/out bevacizumab vs. fluorouracil/leucovorin w/ oxaliplatin (FOLFOX-4) w/ or w/out bevacizumab as first-line treatment for pts w/ metastatic colorectal cancer
  ClinicalTrials.gov Identifier: NCT00069095 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00498407 - Recruiting
  Advanced Colorectal Cancer; Colorectal Cancer
  
• Phase I Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00536809 - Recruiting
  Advanced Colorectal Cancer; Metastatic Colorectal Cancer
  
• Association of MSI, TS, DPD, MVD and EGFR With Chemosensitivity in Stage IV in Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00173472 - Active, not recruiting
  Colorectal Cancer
  
• Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00217711 - Active, not recruiting
  Colorectal Cancer
  
• A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00251485 - Active, not recruiting
  Colorectal Cancer
  
• Effectiveness Study of a Computer-Based Colorectal Cancer Screening Decision Aid
  ClinicalTrials.gov Identifier: NCT00558233 - Enrolling by invitation
  Colorectal Cancer; Health Literacy
  
• Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00209651 - Active, not recruiting
  Colorectal Cancer
  
• Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00220155 - Active, not recruiting
  Colorectal Cancer
  
• Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00227734 - Active, not recruiting
  Colorectal Cancer
  
• A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.
  ClinicalTrials.gov Identifier: NCT00349336 - Active, not recruiting
  Colorectal Cancer
  
• Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00303745 - Active, not recruiting
  Colorectal Cancer
  
• Folic Acid in Preventing Colorectal Polyps in Patients With Previous Colorectal Polyps
  ClinicalTrials.gov Identifier: NCT00512850 - Active, not recruiting
  Colorectal Cancer
  
• Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00215982 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00258232 - Active, not recruiting
  Colorectal Cancer
  
• Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00274872 - Active, not recruiting
  Colorectal Cancer
  
• A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.
  ClinicalTrials.gov Identifier: NCT00353262 - Active, not recruiting
  Colorectal Cancer
  
• Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00416494 - Active, not recruiting
  Colorectal Cancer
  
• Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00199797 - Active, not recruiting
  Colorectal Cancer
  
• Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00291785 - Active, not recruiting
  Colorectal Cancer
  
• Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00467129 - Active, not recruiting
  Colorectal Cancer
  
• Phase II Efficacy Study of AZD6244 in Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00514761 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• Phase III Study of Irinotecan and Cetuximab vs Irinotecan as Second-Line Treatment in Patients with Metastatic, EGFR-Positive Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00063141 - Active, not recruiting
  Colorectal Cancer
  
• ABX-EGF Monotherapy in Subjects with Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00089635 - Active, not recruiting
  Colorectal Cancer; Metastases
  
• A Study Comparing Two Different Treatment Schedules of Intermittent Capecitabine and Oxaliplatin Combined with Bevacizumab As First-Line Treatment (Previously Not Been Treated) for Patients with Metastatic Colorectal Cancer.
  ClinicalTrials.gov Identifier: NCT00118755 - Recruiting
  Colorectal Cancer
  
• Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00063427 - Active, not recruiting
  Colorectal Neoplasms
  
• Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
  ClinicalTrials.gov Identifier: NCT00337389 - Active, not recruiting
  Metastatic Colorectal Cancer; Colon Cancer; Rectal Cancer
  
• Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00230399 - Active, not recruiting
  Colorectal Cancer
  
• Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00345761 - Active, not recruiting
  Colorectal Cancer
  
• Eflornithine Plus Sulindac in Preventing Colorectal Cancer in Patients Who Have Had Surgery to Remove Benign Colorectal Polyps
  ClinicalTrials.gov Identifier: NCT00005882 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Chemotherapy Administered Every 2 Weeks with or without Pegfilgrastim (Neulasta) in Subjects with Advanced Colon Cancer
  ClinicalTrials.gov Identifier: NCT00094809 - Active, not recruiting
  Colon Cancer; Colorectal Cancer; Rectal Cancer
  
• A study of capecitabine in combo w/ XELOX vs fluorouracil/leucovorin w/ oxaliplatin (FOLFOX4) as treatment for pts w/ metastatic colorectal cancer, who have received prior treatment w/ CPT-11 in combo w/ fluorouracil/leucovorin
  ClinicalTrials.gov Identifier: NCT00069108 - Active, not recruiting
  Colorectal Cancer; Metastases
  
• Cetuximab Combined with Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
  ClinicalTrials.gov Identifier: NCT00154102 - Active, not recruiting
  EGFR-expressing metastatic colorectal cancer
  
• Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00062023 - Active, not recruiting
  Colorectal Cancer; stage I colon cancer; stage II colon cancer; stage III colon cancer; stage IV colon cancer
  
• Second Line ColoRectal Cancer Therapy in Combination With FOLFOX
  ClinicalTrials.gov Identifier: NCT00278889 - Active, not recruiting
  Colorectal Cancer
  
• Study of XL999 in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00277303 - Active, not recruiting
  Colorectal Cancer
  
• Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients
  ClinicalTrials.gov Identifier: NCT00354978 - Active, not recruiting
  Colorectal Cancer
  
• Tissue and Serum Collection From Colorectal Cancer Patients
  ClinicalTrials.gov Identifier: NCT00579891 - Active, not recruiting
  Colorectal Cancer
  
• Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps
  ClinicalTrials.gov Identifier: NCT00033319 - Active, not recruiting
  prevention of colorectal cancer; Colon Cancer; Rectal Cancer
  
• Phase I Dose-finding Study of E7070 in Combination with Irinotecan
  ClinicalTrials.gov Identifier: NCT00060567 - Recruiting
  Colorectal Cancer; Colorectal Carcinoma; Colorectal Tumors; Pulmonary Neoplasms; Pulmonary Cancer
  
• A Study of Cetuximab in Patients who have Stage IV Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00055419 - Active, not recruiting
  Colorectal Neoplasms
  
• Evaluating ABX-EGF Plus Best Supportive Care Versus Best Supportive Care in Subjects with Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00113763 - Active, not recruiting
  Colorectal Cancer; Metastases
  
• Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00096330 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Phase I Study of SU006668 in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024063 - Active, not recruiting
  Lung Cancer; Pancreatic Cancer; Gastric Cancer; Renal Cell Cancer; Colorectal Cancer; Colon Cancer; Prostate Cancer; Rectal Cancer; Breast Cancer; ...
  
• Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
  ClinicalTrials.gov Identifier: NCT00004910 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; Colorectal Cancer; Colon Cancer
  
• A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00500292 - Active, not recruiting
  Colorectal; Cancer
  
• Capecitabine in Combination with Oxaliplatin (XELOX) vs. Fluorouracil/Leucovorin as Adjuvant Therapy for Patients who have Undergone Surgery for Colon Carcinoma
  ClinicalTrials.gov Identifier: NCT00069121 - Active, not recruiting
  Colorectal Cancer
  
• STEPP: A Phase 2, Open-Label, Randomized Clinical Trial of Skin Toxicity Treatment in mCRC Subjects Receiving Panitumumab Concomitantly With Second-Line Irinotecan Based Chemotherapy
  ClinicalTrials.gov Identifier: NCT00332163 - Active, not recruiting
  Metastatic Colorectal Cancer; Skin Rash; Skin Toxicities; Colon Cancer; Colorectal Cancer
  
• Circulating Tumor Cells in Patients with Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00133913 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• Phase III Study of Cetuximab, Oxaliplatin, 5-FU/LV vs. Oxaliplatin, 5-FU/LV in Patients with Previously Treated Metastatic, EGFR-Positive Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00061815 - Active, not recruiting
  Colorectal Cancer
  
• Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00291486 - Active, not recruiting
  Colorectal Neoplasms
  
• XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00215722 - Active, not recruiting
  Colorectal Carcinoma
  
• Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00220246 - Active, not recruiting
  Colorectal Neoplasms
  
• A Safety and Effectiveness Study of Aroplatin in Patients with Advanced Colorectal Cancer Resistant to Standard Therapies
  ClinicalTrials.gov Identifier: NCT00043199 - Active, not recruiting
  Colorectal Neoplasms
  
• Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00373022 - Active, not recruiting
  Anxiety Disorder; Colorectal Cancer; Depression; Psychosocial Effects/Treatment
  
• Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After Treatment
  ClinicalTrials.gov Identifier: NCT00313794 - Active, not recruiting
  Colorectal Neoplasms
  
• Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00438737 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Previously Untreated, Unresectable Liver Metastases From Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00450346 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00482222 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung
  ClinicalTrials.gov Identifier: NCT00557102 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Improving the Frequency of Colonoscopy in Patients With a Previous Colorectal Polyp
  ClinicalTrials.gov Identifier: NCT00397969 - Active, not recruiting
  Colorectal Cancer; Precancerous/Nonmalignant Condition
  
• Randomized Controlled Trial to Evaluate Laparoscopic Vs Open Surgery for Colorectal Cancer（JCOG 0404,CRC Surg-LAP/OPEN)
  ClinicalTrials.gov Identifier: NCT00147134 - Recruiting
  Colorectal Cancer
  
• Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00544349 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
  ClinicalTrials.gov Identifier: NCT00408551 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy and Bevacizumab in Treating Patients With Colorectal Cancer That Has Spread to the Liver
  ClinicalTrials.gov Identifier: NCT00492999 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction
  ClinicalTrials.gov Identifier: NCT00004911 - Active, not recruiting
  Gastric Cancer; Colorectal Cancer; Colon Cancer; Rectal Cancer
  
• Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
  ClinicalTrials.gov Identifier: NCT00314353 - Active, not recruiting
  Colorectal Neoplasms
  
• Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00361842 - Active, not recruiting
  Colorectal Neoplasms
  
• A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00191984 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• Combination Chemotherapy in Treating Patients With Colorectal Cancer and Liver Metastases
  ClinicalTrials.gov Identifier: NCT00268398 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer
  ClinicalTrials.gov Identifier: NCT00559858 - Recruiting
  Breast Cancer; Colorectal Cancer; Palmar-Plantar Erythrodysesthesia
  
• A Study of 1018 ISS Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00403052 - Active, not recruiting
  Colorectal Neoplasms
  
• Promoting Colorectal Cancer Screening in Rural Colorado
  ClinicalTrials.gov Identifier: NCT00137592 - Not yet recruiting
  Colorectal Cancer